The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nalanda India Equity Fund Ltd

Nalanda India Equity Fund Limited 3 September 2026 Bombay Stock Exchange Limited Fax: +91- 22- 22723121 Phiroze Jeejeebhoy Towers Tel: +91-22- 22721233/34 Dalal Street Ext. 8013/ 8184/ 8332 Mumbai - 400 001 +91-22-66545695 Email: corp.relations@bseindia.com corp.comm@bseindia.com Re: Reporting of acquisition of shares of Jyothy Laboratories Limited Please find attached the relevant Forms as per the relevant regulations in respect of the above mentioned. The originals will be couriered to you shortly. Thank you for your attention. Yours faithfully ----------------------------------- Name: Arshad Goodur Position: Director Registered office: 32, St Georges Street, Port Louis, Mauritius Tel: (230) 405 2000 Fax: (230) 212 5265 Annexure-2 Format for Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company (TC) JYOTHY LABORATORIES LIMITED Name (s) of the acquirer and Persons Acting in NALANDA INDIA EQUITY FUND LIMITED Concert (PAC) with the acquirer Whether the acquirer belongs to No Promoter/Promoter group Name(s) of the Stock Exchange(s) where the shares NSE & BSE of TC are Listed Details of the disposal of shares/voting rights/holding Number % w.r.t. total % w.r.t. of the Acquirer and PAC share/voting total diluted capital share/voting wherever capital of applicable the TC (*) Before the Purcahse under consideration, holding of : a) Shares carrying voting rights 24,838,446 6.76 6.76 b) Shares in the nature of encumbrance (pledge/ lien/ non-disposal undertaking/ others) c) Voting rights (VR) otherwise than by shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) 24,838,446 6.76 6.76 Details of buy a) Shares carrying voting rights sold 3,102,384 0.85 0.85 b) VRs acquired / sold otherwise than by shares c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold d) Shares encumbered/invoked/released by the acquirer e) Total (a+b+c+/-d) 3,102,384 0.85 0.85 After the disposal holding of: a) Shares carrying voting rights 27,940,830 7.61 7.61 b) Shares encumbered with the acquirer c) VRs acquired otherwise than by equity shares d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition e) Total (a+b+c+d) 27,940,830 7.61 7.61 6. Mode of sale (eg. Open market / off market / public Exchange issues / rights issues / preferential allotment / inter-se transfer etc). 7. Date of sale of shares Trade Date 02-Sep-2026 Settlement Date: 03-Sep-2026 8. Equity share capital / total voting capital of the TC 367,214,511 before the said purchase 9. Equity share capital / total voting capital of the TC 367,214,511 before the said purchase 10. Total diluted share / voting capital of the TC after the 0 said purchase (*) Total share capital/voting capital to be taken as per the latest filing done by the company to the stock exchange under clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. Signature of the seller / Authorised Signatory Place : Mauritius Date : 03 September 2026